Funding for this research was provided by:
Received: 15 December 2019
Accepted: 20 January 2022
First Online: 3 February 2022
: Data used is publicly available and conforms with patient consent.
: Not applicable.
: Martin Lavallee worked on this project as a contractor for Bayer from January to July 2018. Martin is now a PhD student in Biostatistics at Virginia Commonwealth University and an intern for LTS Computing LLC. Lee Evans and Theresa Yu are employees of LTS Computing LLC. LTS manages the real-world evidence platform (OHDSI/OMOP common data model) for Bayer.